NXTC FY 2022 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena

NXTCNextCure, Inc.

$36M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$76M

Net Income

-$75M

EPS (Diluted)

$-32.32

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$56M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$184M

Total Liabilities

$17M

Stockholders' Equity

$168M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$76M	-$71M	-7.3%
Net Income	-$75M	-$69M	-7.7%